Goran Ando - Net Worth and Insider Trading
Goran Ando Net Worth
The estimated net worth of Goran Ando is at least $120,717 dollars as of 2024-09-20. Goran Ando is the Director of EyePoint Pharmaceuticals Inc and owns about 13,150 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $120,717. Details can be seen in Goran Ando's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Goran Ando has not made any transactions after 2024-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Goran Ando
Goran Ando Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Goran Ando owns 3 companies in total, including Cartesian Therapeutics Inc (RNAC) , EyePoint Pharmaceuticals Inc (EYPT) , and Enzon Pharmaceuticals Inc (ENZN) .
Click here to see the complete history of Goran Ando’s form 4 insider trades.
Insider Ownership Summary of Goran Ando
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2020-04-24 | director |
| EYPT | EyePoint Pharmaceuticals Inc | 2024-08-21 | director |
| ENZN | Enzon Pharmaceuticals Inc | 2008-11-14 | director |
Goran Ando Latest Holdings Summary
Goran Ando currently owns a total of 1 stock. Goran Ando owns 13,150 shares of EyePoint Pharmaceuticals Inc (EYPT) as of August 21, 2024, with a value of $120,717.
Latest Holdings of Goran Ando
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2024-08-21 | 13,150 | 9.18 | 120,717 |
Holding Weightings of Goran Ando
Goran Ando Form 4 Trading Tracker
According to the SEC Form 4 filings, Goran Ando has made a total of 1 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 5,000 shares on August 21, 2024, which cost Goran Ando around $39,750.
Insider Trading History of Goran Ando
- 1
Goran Ando Trading Performance
GuruFocus tracks the stock performance after each of Goran Ando's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goran Ando is %. GuruFocus also compares Goran Ando's trading performance to market benchmark return within the same time period. The performance of stocks bought by Goran Ando within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Goran Ando's insider trading performs compared to the benchmark.
Performance of Goran Ando
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.32 |  | | | | |
| Relative Return to S&P 500(%) | -2.54 | | | | | |
Goran Ando Ownership Network
Goran Ando Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Goran Ando is the director of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Goran Ando made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,231,332 shares made by Timothy A Springer , a net purchase of 7,500 shares made by Timothy C Barabe , and a net sale of 2,932 shares made by Carsten Brunn .
In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 15,516 shares, with a net purchase of 15,516 shares. During the past 18 months, 121 shares of Cartesian Therapeutics Inc (RNAC) were sold and 56,293 shares were bought by its insiders, resulting in a net purchase of 56,172 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Goran Ando Mailing Address
Above is the net worth, insider trading, and ownership report for Goran Ando. Currently GuruFocus does not have mailing address information for Goran Ando.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
